410 related articles for article (PubMed ID: 32729049)
1. Dysthyroid optic neuropathy: evaluation and management.
Dolman PJ
J Endocrinol Invest; 2021 Mar; 44(3):421-429. PubMed ID: 32729049
[TBL] [Abstract][Full Text] [Related]
2. Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.
Tramunt B; Imbert P; Grunenwald S; Boutault F; Caron P
Clin Endocrinol (Oxf); 2019 Jan; 90(1):208-213. PubMed ID: 30339291
[TBL] [Abstract][Full Text] [Related]
3. Dysthyroid Optic Neuropathy.
Potvin ARGG; Pakdel F; Saeed P
Ophthalmic Plast Reconstr Surg; 2023 Dec; 39(6S):S65-S80. PubMed ID: 38054987
[TBL] [Abstract][Full Text] [Related]
4. Ocular Hypertension, Glaucoma or Compressive Neuropathy in Patient with Active TED.
Stoyanova NS; Konareva-Kostianeva MI; Mitkova-Hristova VT
Folia Med (Plovdiv); 2020 Jun; 62(2):418-423. PubMed ID: 32666771
[TBL] [Abstract][Full Text] [Related]
5. Dysthyroid Optic Neuropathy.
Saeed P; Tavakoli Rad S; Bisschop PHLT
Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S60-S67. PubMed ID: 29927882
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics of dysthyroid optic neuropathy].
Elyashiv S; Skaat A; Ben Simon G; Huna-Baron R
Harefuah; 2015 Feb; 154(2):98-102, 137. PubMed ID: 25856861
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.
McKeag D; Lane C; Lazarus JH; Baldeschi L; Boboridis K; Dickinson AJ; Hullo AI; Kahaly G; Krassas G; Marcocci C; Marinò M; Mourits MP; Nardi M; Neoh C; Orgiazzi J; Perros P; Pinchera A; Pitz S; Prummel MF; Sartini MS; Wiersinga WM;
Br J Ophthalmol; 2007 Apr; 91(4):455-8. PubMed ID: 17035276
[TBL] [Abstract][Full Text] [Related]
8. Bilateral optic nerve edema presenting as initial manifestation of thyroid eye disease.
Wilson ME; Kim C; Carrasco J
Orbit; 2016 Oct; 35(5):288-91. PubMed ID: 27486810
[TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography measurements in compressive optic neuropathy associated with dysthyroid orbitopathy.
Park KA; Kim YD; In Woo K; Kee C; Han JC
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1617-1624. PubMed ID: 27169807
[TBL] [Abstract][Full Text] [Related]
10. Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy.
Miśkiewicz P; Rutkowska B; Jabłońska A; Krzeski A; Trautsolt-Jeziorska K; Kęcik D; Milczarek-Banach J; Pirko-Kotela K; Samsel A; Bednarczuk T
Endokrynol Pol; 2016; 67(2):166-73. PubMed ID: 26884288
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic methods for dysthyroid optic neuropathy: A systematic review and analysis.
Sio SWC; Chan BKT; Aljufairi FMAA; Sebastian JU; Lai KKH; Tham CCY; Pang CP; Chong KKL
Surv Ophthalmol; 2024; 69(3):403-410. PubMed ID: 38007201
[TBL] [Abstract][Full Text] [Related]
12. Visual field and orbital computed tomography correlation in dysthyroid optic neuropathy due to thyroid eye disease.
Starks VS; Reinshagen KL; Lee NG; Freitag SK
Orbit; 2020 Apr; 39(2):77-83. PubMed ID: 31057005
[No Abstract] [Full Text] [Related]
13. Clinical and Visual Outcomes of Dysthyroid Optic Neuropathy After Surgical Orbital Decompression.
Currò N; Guastella C; Pirola G; Calonghi B; Bottari de Castello A; Fazio MC; di Benedetto S; Minorini V; Daga M; Contarino A; Muller I; Arosio M; Viola F; Pignataro L; Salvi M
Thyroid; 2023 Jun; 33(6):743-751. PubMed ID: 37140534
[No Abstract] [Full Text] [Related]
14. Intraocular pressure lowering effect of orbital decompression is related to increased venous outflow in Graves orbitopathy.
Onaran Z; Konuk O; Oktar SÖ; Yücel C; Unal M
Curr Eye Res; 2014 Jul; 39(7):666-72. PubMed ID: 24502333
[TBL] [Abstract][Full Text] [Related]
15. Subclinical dysthyroid optic neuropathy: tritan deficiency as an early sign of dysthyroid optic neuropathy.
Garip-Kuebler A; Halfter K; Reznicek L; Klingenstein A; Priglinger S; Hintschich CR
Br J Ophthalmol; 2021 Jul; 105(7):1019-1023. PubMed ID: 32699051
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic outcomes and influence factors of maximal orbital decompression in the treatment of severe dysthyroid optic neuropathy].
Wang Y; Li YY; Yang N; Ma R; Xiao LH
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):416-423. PubMed ID: 28606262
[TBL] [Abstract][Full Text] [Related]
17. Acute dysthyroid optic neuropathy exacerbated by orbital radiotherapy.
Hersh D; Kinnar M
Orbit; 2014 Oct; 33(5):385-7. PubMed ID: 24841498
[TBL] [Abstract][Full Text] [Related]
18. Dysthyroid optic neuropathy: a case series at a tertiary ophthalmic referral centre.
Chung IY; Hardy TG; Khong JJ
Eye (Lond); 2024 Apr; 38(6):1168-1172. PubMed ID: 38081935
[TBL] [Abstract][Full Text] [Related]
19. Dysthyroid optic neuropathy: atypical initial presentation and persistent visual loss.
Mensah A; Vignal-Clermont C; Mehanna C; Morel X; Galatoire O; Jacomet PV; Morax S
Orbit; 2009; 28(6):354-62. PubMed ID: 19929659
[TBL] [Abstract][Full Text] [Related]
20. The Changes in Optic Nerve after Orbital Decompression Surgery for Thyroid Eye Disease and Case Reports of Ischemic Optic Neuropathy.
Hsia Y; Hsiao CC; Wei YH; Lai IW; Lin CW; Liao SL
Biomed Res Int; 2022; 2022():4808194. PubMed ID: 35265712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
